Amerisource Bergen Corp. logo

ABC

Amerisource Bergen Corp.

$148.94

Earnings Summary

Revenue
$60064.6Mn
Net Profits
$406.96Mn
Net Profit Margins
0.68%
PE Ratio
17.42

Highlights

Revenue:

Amerisource Bergen Corp.’s revenue jumped 12.47% since last year same period to $60064.6Mn in the Q2 2022. On a quarterly growth basis, Amerisource Bergen Corp. has generated 4.06% jump in its revenue since last 3-months.

Net Profits:

Amerisource Bergen Corp.’s net profit jumped 39.31% since last year same period to $406.96Mn in the Q2 2022. On a quarterly growth basis, Amerisource Bergen Corp. has generated -25.74% fall in its net profits since last 3-months.

Net Profit Margins:

Amerisource Bergen Corp.’s net profit margin jumped 23.87% since last year same period to 0.68% in the Q2 2022. On a quarterly growth basis, Amerisource Bergen Corp. has generated -28.64% fall in its net profit margins since last 3-months.

PE Ratio:

Amerisource Bergen Corp.’s price-to-earnings ratio after this Q2 2022 earnings stands at 17.42.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Amerisource Bergen Corp. post its latest quarter earnings

EPS Estimate Current Quarter
2.56
EPS Estimate Current Year
2.56

Highlights

EPS Estimate Current Quarter:

Amerisource Bergen Corp.’s earning per share (EPS) estimates for the current quarter stand at 2.56 - a -12.63% fall from last quarter’s estimates.

EPS Estimate Current Year:

Amerisource Bergen Corp.’s earning per share (EPS) estimates for the current year stand at 2.56.

Key Ratios

Key ratios of the Amerisource Bergen Corp. post its Q2 2022 earnings

Return on Assets (ROA)
0.03
Return on Equity (ROE)
0.39
Dividend Per Share (DPS)
1.82

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amerisource Bergen Corp.’s return on assets (ROA) stands at 0.03.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amerisource Bergen Corp.’s return on equity (ROE) stands at 0.39.

Dividend Per Share (DPS):

Amerisource Bergen Corp. declared 1.82 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-04
2.93
3.22
9.9%

Company Information

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work-and powered by our 22,000 associates-we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $185 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries.

Organisation
Amerisource Bergen Corp.
Headquarters
Chesterbrook, Pennsylvania, US
Employees
2.02K
Industry
Distribution Services
CEO
Steven Collis